ERIC ROHREN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Radiology
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleInterim Chair
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Radiation Oncology
    DivisionRadiation Oncology

    TitleChair
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Radiology
    DivisionRadiology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Currie GM, Hawk KE, Rohren EM. Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations. Semin Nucl Med. 2024 Jun 07. PMID: 38851934.
      Citations:    Fields:    
    2. Elmohr MM, Javed Z, Dubey P, Jordan JE, Shah L, Nasir K, Rohren EM, Lincoln CM. Social Determinants of Health Framework to Identify and Reduce Barriers to Imaging in Marginalized Communities. Radiology. 2024 Feb; 310(2):e223097. PMID: 38376404; PMCID: PMC10902599.
      Citations:    Fields:    Translation:Humans
    3. Rohren EM. Promoting a Robust Pipeline for Nuclear Medicine Practitioners. Acad Radiol. 2023 04; 30(4):763-764. PMID: 36710100.
      Citations:    Fields:    Translation:Humans
    4. Currie GM, Rohren EM. Radiation Dosimetry, Artificial Intelligence and Digital Twins: Old Dog, New Tricks. Semin Nucl Med. 2023 05; 53(3):457-466. PMID: 36379728.
      Citations:    Fields:    Translation:Humans
    5. Premji S, Barbieri A, Roth C, Rohren EM, Rivero G, Teegavarapu SP. An Unusual Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Case Rep Hematol. 2022; 2022:4700787. PMID: 35721802; PMCID: PMC9203203.
      Citations:    
    6. Brophy J, Henkle G, Rohren EM. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination. Clin Nucl Med. 2022 Feb 01; 47(2):174-175. PMID: 34269723; PMCID: PMC8745954.
      Citations:    
    7. Currie G, Rohren E. Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape. Semin Nucl Med. 2022 07; 52(4):498-503. PMID: 34972549.
      Citations: 1     Fields:    Translation:Humans
    8. Varghese J, Rohren E, Guofan X. Radioiodine Imaging and Treatment in Thyroid Disorders. Neuroimaging Clin N Am. 2021 Aug; 31(3):337-344. PMID: 34243868.
      Citations: 1     Fields:    Translation:Humans
    9. Currie G, Rohren E. Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning. Semin Nucl Med. 2021 03; 51(2):102-111. PMID: 33509366.
      Citations: 4     Fields:    Translation:Humans
    10. Zukotynski KA, Niederkohr RD, Greenspan BS, Prior JO, Sch?der H, Seltzer MA, Rohren EM, Yoo DC. An International Survey of PET/CT Clinical Reporting. J Nucl Med. 2019 Apr; 60(4):478-479. PMID: 30877176.
      Citations:    
    11. Kairemo K, Rohren EM, Anderson PM, Ravizzini G, Rao A, Macapinlac HA, Subbiah V. Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST. ESMO Open. 2019; 4(1):e000439. PMID: 30962954; PMCID: PMC6435244.
      Citations: 7     
    12. Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, Ravizzini G, Kleinerman E, Macapinlac H, Rohren E. Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clin Cancer Res. 2019 07 01; 25(13):3802-3810. PMID: 30733229; PMCID: PMC6606382.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    13. Etchebehere E, Kairemo K, Rohren E, Araujo J, Macapinlac H, Brito AE. Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy? Radiol Bras. 2019 Jan-Feb; 52(1):33-40. PMID: 30804613; PMCID: PMC6383535.
      Citations: 3     
    14. Kairemo K, Milton DR, Etchebehere E, Rohren EM, Macapinlac HA. Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience. Curr Radiopharm. 2018; 11(2):147-152. PMID: 29956640.
      Citations: 4     Fields:    Translation:Humans
    15. Rohren EM, Macapinlac HA. Spectrum of Benign Bone Conditions on NaF-PET. Semin Nucl Med. 2017 07; 47(4):392-396. PMID: 28583278.
      Citations: 2     Fields:    Translation:Humans
    16. Takeuchi S, Rohren EM, Abdel-Wahab R, Xiao L, Morris JS, Macapinlac HA, Hassan MM, Kaseb AO. Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers. Eur J Nucl Med Mol Imaging. 2017 Jun; 44(6):969-978. PMID: 27942837; PMCID: PMC5400685.
      Citations: 5     Fields:    Translation:HumansCells
    17. Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst. 2016 12; 108(12). PMID: 27576731; PMCID: PMC5241894.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    18. Rydzak C, Chauhan A, Gupta N, Chuang HH, Rohren EM, Bhosale PR. Fat-Containing Hypermetabolic Masses on FDG PET/CT: A Spectrum of Benign and Malignant Conditions. AJR Am J Roentgenol. 2016 Nov; 207(5):1095-1104. PMID: 27490138.
      Citations: 1     Fields:    Translation:Humans
    19. Etchebehere EC, Fox P, Macapinlac H, Rohren E, Milton D. Reply: Prediction vs. Prognostication and Guarantee-Time Bias: Steering Clear of the Pitfalls of Interpreting Observational Data. J Nucl Med. 2016 06; 57(6):991. PMID: 27081171.
      Citations:    Fields:    
    20. Araujo JC, Erwin WD, Wendt RE, Swanston NM, Fox P, Macapinlac HA, Rohren EM, Etchebehere EC, Milton DR. Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy. Clin Nucl Med. 2016 Apr; 41(4):268-73. PMID: 26828141.
      Citations: 7     Fields:    Translation:Humans
    21. Lee JH, Rohren EM, Tamm EP, Bhosale P. State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2016 Apr; 25(2):375-400. PMID: 27013371; PMCID: PMC4808582.
      Citations: 13     Fields:    Translation:Humans
    22. Amini B, Yellapragada S, Shah S, Rohren E, Vikram R. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias. Radiol Clin North Am. 2016 May; 54(3):581-96. PMID: 27153790.
      Citations: 5     Fields:    Translation:Humans
    23. Sher AC, Seghers V, Paldino MJ, Dodge C, Krishnamurthy R, Krishnamurthy R, Rohren EM. Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study. AJR Am J Roentgenol. 2016 Mar; 206(3):623-31. PMID: 26901021.
      Citations: 24     Fields:    Translation:Humans
    24. Lyons K, Seghers V, Sorensen JI, Zhang W, Paldino MJ, Krishnamurthy R, Rohren EM. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Nov; 205(5):1094-101. PMID: 26496558.
      Citations: 14     Fields:    Translation:Humans
    25. Etchebehere EC, Araujo JC, Swanston NM, Macapinlac HA, Rohren EM, Milton DR. Factors affecting (223)Ra therapy: clinical experience after 532 cycles from a single institution. Eur J Nucl Med Mol Imaging. 2016 Jan; 43(1):8-20. PMID: 26416392.
      Citations: 21     Fields:    Translation:Humans
    26. Lyons K, Seghers V, Williams JL, Sorensen JI, Paldino MJ, Krishnamurthy R, Rohren EM. Qualitative FDG PET Image Assessment Using Automated Three-Segment MR Attenuation Correction Versus CT Attenuation Correction in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015 Sep; 205(3):652-8. PMID: 26295654.
      Citations: 2     Fields:    Translation:Humans
    27. Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, Moody T, Macapinlac HA. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT. J Nucl Med. 2015 Oct; 56(10):1507-12. PMID: 26135112; PMCID: PMC5025941.
      Citations: 31     Fields:    Translation:Humans
    28. Etchebehere EC, Araujo JC, Fox PS, Swanston NM, Macapinlac HA, Rohren EM. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. J Nucl Med. 2015 Aug; 56(8):1177-84. PMID: 26069307.
      Citations: 48     Fields:    Translation:Humans
    29. Subbiah V, Anderson P, Rohren E. Alpha Emitter Radium 223 in High-Risk Osteosarcoma: First Clinical Evidence of Response and Blood-Brain Barrier Penetration. JAMA Oncol. 2015 May; 1(2):253-5. PMID: 26181034.
      Citations: 13     Fields:    Translation:Humans
    30. Rohren EM. PET/Computed Tomography and Patient Outcomes in Melanoma. PET Clin. 2015 Apr; 10(2):243-54. PMID: 25829089.
      Citations:    
    31. Kubicki SL, Richardson ML, Martin T, Rohren E, Wei W, Amini B. The acetabular fossa hot spot on 18F-FDG PET/CT: epidemiology, natural history, and proposed etiology. Skeletal Radiol. 2015 Jan; 44(1):107-14. PMID: 25283982.
      Citations: 2     Fields:    Translation:Humans
    32. Takeuchi S, Khiewvan B, Fox PS, Swisher SG, Rohren EM, Bassett RL, Macapinlac HA. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2014 May; 41(5):906-14. PMID: 24442598.
      Citations: 16     Fields:    Translation:Humans
    33. Bhosale P, Balachandran A, Vikram R, Viswanathan C, Macapinlac H, Rohren E, Prativadi R. What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies? Int J Mol Imaging. 2013; 2013:476786. PMID: 24455242; PMCID: PMC3888763.
      Citations: 4     
    34. Carkaci S, Sherman CT, Ozkan E, Adrada BE, Wei W, Rohren EM, Mawlawi OR, Ueno NT, Buchholz TA, Yang WT. (18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging. 2013 Dec; 40(12):1809-16. PMID: 23877633.
      Citations: 6     Fields:    Translation:Humans
    35. Niederkohr RD, Greenspan BS, Prior JO, Seltzer MA, Zukotynski KA, Rohren EM, Sch?der H. Reporting guidance for oncologic 18F-FDG PET/CT imaging. J Nucl Med. 2013 May; 54(5):756-61. PMID: 23575994.
      Citations:    
    36. Bronstein Y, Ng CS, Rohren E, Ross MI, Lee JE, Cormier J, Johnson VE, Hwu WJ. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012 Apr; 198(4):902-8. PMID: 22451559; PMCID: PMC3880209.
      Citations: 11     Fields:    Translation:Humans
    37. Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fakih MG, Fleshman JW, Fuchs CS, Grem JL, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C, Freedman-Cass DA, National Comprehensive Cancer Network. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012 Apr; 10(4):449-54. PMID: 22491045.
      Citations: 19     Fields:    Translation:Humans
    38. Adejolu M, Huo L, Rohren E, Santiago L, Yang WT. False-positive lesions mimicking breast cancer on FDG PET and PET/CT. AJR Am J Roentgenol. 2012 Mar; 198(3):W304-14. PMID: 22358030.
      Citations: 39     Fields:    Translation:Humans
    39. Carkaci S, Adrada BE, Rohren E, Wei W, Quraishi MA, Mawlawi O, Buchholz TA, Yang W. Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant? Acad Radiol. 2012 May; 19(5):535-41. PMID: 22300741; PMCID: PMC4128395.
      Citations: 2     Fields:    Translation:Humans
    40. Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A, Ueno NT, Buchholz TA. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1381-6. PMID: 22284689.
      Citations: 8     Fields:    Translation:Humans
    41. Naing A, Kurzrock R, Burger A, Gupta S, Lei X, Busaidy N, Hong D, Chen HX, Doyle LA, Heilbrun LK, Rohren E, Ng C, Chandhasin C, LoRusso P. Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res. 2011 Sep 15; 17(18):6052-60. PMID: 21750201; PMCID: PMC3176947.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    42. Jackson J, Pan T, Tonkopi E, Swanston N, Macapinlac HA, Rohren EM. Implementation of automated tube current modulation in PET/CT: prospective selection of a noise index and retrospective patient analysis to ensure image quality. J Nucl Med Technol. 2011 Jun; 39(2):83-90. PMID: 21565950.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    43. Bronstein Y, Tummala S, Rohren E. F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review. Clin Nucl Med. 2011 Feb; 36(2):96-100. PMID: 21220969.
      Citations: 8     Fields:    Translation:Humans
    44. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer. 2010 Oct 01; 116(19):4487-94. PMID: 20629031.
      Citations: 6     Fields:    Translation:Humans
    45. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma. Oncology. 2010; 78(5-6):316-22. PMID: 20699623.
      Citations: 10     Fields:    Translation:Humans
    46. Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, Macapinlac HA, Iyer RB. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44. PMID: 20683399.
      Citations: 13     Fields:    Translation:Humans
    47. De Giorgi U, Mego M, Rohren EM, Liu P, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M, Ueno NT. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer. J Nucl Med. 2010 Aug; 51(8):1213-8. PMID: 20660382.
      Citations: 22     Fields:    Translation:HumansCells
    48. Tonkopi E, Chi PC, Mawlawi O, Riegel AC, Rohren EM, Macapinlac HA, Pan T. Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients. J Appl Clin Med Phys. 2010 Feb 04; 11(1):3073. PMID: 20160693; PMCID: PMC3883558.
      Citations:    Fields:    Translation:Humans
    49. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, Ajani JA. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer. 2009 Nov 15; 115(22):5184-92. PMID: 19685531.
      Citations: 24     Fields:    Translation:Humans
    50. Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J, Stafford RJ, Tari AM, Hortobagyi GN, Ueno NT. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009 Jun; 10(6):606-14. PMID: 19482249.
      Citations: 48     Fields:    Translation:Humans
    51. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009 Jul 10; 27(20):3303-11. PMID: 19451443.
      Citations: 46     Fields:    Translation:HumansCells
    52. Rohren EM, Macapinlac HA. PET Imaging of Prostate Cancer: Other Tracers. PET Clin. 2009 Apr; 4(2):185-92. PMID: 27157010.
      Citations:    Fields:    
    53. Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, Raymond AK, Lewis VO, Anderson PM, Bassett RL, Harrell RK, Marom EM. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009 Mar; 50(3):340-7. PMID: 19258257.
      Citations: 62     Fields:    Translation:Humans
    54. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med. 2009 Feb; 50(2):231-8. PMID: 19164229.
      Citations: 24     Fields:    Translation:Humans
    55. Erasmus JJ, Rohren EM, Hustinx R. PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers. PET Clin. 2008 Apr; 3(2):135-45. PMID: 27156458.
      Citations: 1     Fields:    
    56. Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med. 2004 Apr; 34(2):134-53. PMID: 15031813.
      Citations: 4     Fields:    Translation:Humans
    ROHREN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (197)
    Explore
    _
    Co-Authors (66)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _